Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell
Lung Cancer (NSCLC) provide recommended management for patients with NSCLC …
Lung Cancer (NSCLC) provide recommended management for patients with NSCLC …
Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology
This selection from the NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC)
focuses on targeted therapies and immunotherapies for metastatic NSCLC, because …
focuses on targeted therapies and immunotherapies for metastatic NSCLC, because …
NCCN guidelines insights: non–small cell lung cancer, version 5.2018
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of
management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the …
management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the …
NCCN guidelines insights: non–small cell lung cancer, version 4.2016
These NCCN Guidelines Insights focus on recent updates in the 2016 NCCN Guidelines for
Non–Small Cell Lung Cancer (NSCLC; Versions 1–4). These NCCN Guidelines Insights will …
Non–Small Cell Lung Cancer (NSCLC; Versions 1–4). These NCCN Guidelines Insights will …
Ten years of progress in non–small cell lung cancer
DS Ettinger - Journal of the National Comprehensive Cancer …, 2012 - jnccn.org
Lung cancer is the leading cause of cancer death in the United States in both men and
women. An estimated 226,160 new cases will be diagnosed in 2012, and 160,340 deaths …
women. An estimated 226,160 new cases will be diagnosed in 2012, and 160,340 deaths …
Non–small cell lung cancer, version 2.2013
These NCCN Guidelines Insights focus on the diagnostic evaluation of suspected lung
cancer. This topic was the subject of a major update in the 2013 NCCN Clinical Practice …
cancer. This topic was the subject of a major update in the 2013 NCCN Clinical Practice …
NCCN guidelines insights: non–small cell lung cancer, version 1.2020: featured updates to the NCCN guidelines
DS Ettinger, DE Wood, C Aggarwal, DL Aisner… - Journal of the National …, 2019 - jnccn.org
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of
management for NSCLC. These NCCN Guidelines Insights focus on recent updates in …
management for NSCLC. These NCCN Guidelines Insights focus on recent updates in …
[HTML][HTML] Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy
Abstract The 1st ESMO Consensus Conference on lung cancer was held in Lugano,
Switzerland on 21 and 22 May 2010 with the participation of a multidisciplinary panel of …
Switzerland on 21 and 22 May 2010 with the participation of a multidisciplinary panel of …
[HTML][HTML] Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?
Non-small-cell lung cancer (NSCLC) is a leading cause of malignancy-related mortality in
the Western world. Despite advances in early detection and standard treatment, NSCLC is …
the Western world. Despite advances in early detection and standard treatment, NSCLC is …
NCCN guidelines® Insights: non–small cell lung cancer, version 2.2023: featured updates to the NCCN guidelines
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) provide recommendations
for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus …
for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus …